Kidney/Renal Function Test Market by Product (Dipsticks, Reagents, Disposables), Type (Urine Test (Urine Protein, Microalbumin, Creatinine Clearance), Blood Test (Serum Creatinine, BUN)), End User -Global Forecast to 2022
“Kidney Function/Renal Function market is projected to grow at a CAGR of 6.1%.”
The global kidney function tests market is expected to reach USD 790.1 million by 2022 from USD 586.5 million in 2017 at a CAGR of 6.1% during the forecast period. Factors such as the rising prevalence of kidney disease, growing prevalence of diabetes and hypertension, increasing geriatric population, and the rise in alcohol consumption are driving the growth of this market. On the other hand, unfavorable healthcare reforms in key markets are expected to restrict market growth to a certain extent.
“The dipsticks segment is expected to hold the largest share of the market in 2017.”
On the basis of product, the kidney function tests market is segmented into dipsticks, reagents, and disposables. The dipsticks segment is expected to account for the largest share of the market in 2017. The large share and high-growth rate of this product segment can be attributed to the cost-effectiveness of dipstick testing and its widespread application in healthcare.
“The urine tests segment is projected to grow at the highest CAGR during the forecast period.”
By type, the market is segmented into urine and blood tests. In 2017, the urine tests segment is expected to account for the largest share of the kidney function tests market. The increasing usage of urine dipsticks analysis, the ease in sample collection technique compared to blood tests and the limited risk of infection during sample collection are factors driving the growth of this segment.
“Asia Pacific to witness the highest growth during the forecast period.”
Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2017–2022. Factors such as the region’s rising geriatric population, increasing incidence of non-communicable diseases, and the growing number of conferences and campaigns to create awareness regarding kidney diseases are key factors driving market growth.
Break of primary participants was as mentioned below:
Research Coverage
The report provides a picture of the market across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as by product, type, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater share of the concerned market. Firms purchasing the report could use any one or a combination of the below-mentioned strategies for strengthening their market shares.
The report provides insights on the following pointers:
The global kidney function tests market is expected to reach USD 790.1 million by 2022 from USD 586.5 million in 2017 at a CAGR of 6.1% during the forecast period. Factors such as the rising prevalence of kidney disease, growing prevalence of diabetes and hypertension, increasing geriatric population, and the rise in alcohol consumption are driving the growth of this market. On the other hand, unfavorable healthcare reforms in key markets are expected to restrict market growth to a certain extent.
“The dipsticks segment is expected to hold the largest share of the market in 2017.”
On the basis of product, the kidney function tests market is segmented into dipsticks, reagents, and disposables. The dipsticks segment is expected to account for the largest share of the market in 2017. The large share and high-growth rate of this product segment can be attributed to the cost-effectiveness of dipstick testing and its widespread application in healthcare.
“The urine tests segment is projected to grow at the highest CAGR during the forecast period.”
By type, the market is segmented into urine and blood tests. In 2017, the urine tests segment is expected to account for the largest share of the kidney function tests market. The increasing usage of urine dipsticks analysis, the ease in sample collection technique compared to blood tests and the limited risk of infection during sample collection are factors driving the growth of this segment.
“Asia Pacific to witness the highest growth during the forecast period.”
Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2017–2022. Factors such as the region’s rising geriatric population, increasing incidence of non-communicable diseases, and the growing number of conferences and campaigns to create awareness regarding kidney diseases are key factors driving market growth.
Break of primary participants was as mentioned below:
- By Company Type: Tier I: 55%, Tier II: 25%, Tier III: 20%
- By Designation: C-Level Executives: 43%, Directors: 32%, Others: 25%
- By Region: North America: 38%, Europe: 23%, Asia Pacific: 29%, RoW: 10%
Research Coverage
The report provides a picture of the market across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as by product, type, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater share of the concerned market. Firms purchasing the report could use any one or a combination of the below-mentioned strategies for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the kidney function test market. The report analyzes the market by type, product, and end user.
- Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, product approvals, and product launches in the kidney function test market
- Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various kidney function tests across regions
- Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the kidney function test market
- Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the kidney function test market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 KIDNEY FUNCTION TESTS: MARKET OVERVIEW
4.2 KIDNEY FUNCTION TESTS MARKET SHARE, BY PRODUCT AND REGION
4.3 KIDNEY FUNCTION TESTS MARKET, BY TYPE
4.4 KIDNEY FUNCTION TESTS MARKET, BY END USER
4.5 GEOGRAPHIC SNAPSHOT OF THE KIDNEY FUNCTION TESTS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of kidney disease
5.2.1.2 Growing prevalence of diabetes and hypertension
5.2.1.3 Rapid growth in geriatric population
5.2.1.4 Rise in consumption of alcohol
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable healthcare reforms in the US
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
6 KIDNEY FUNCTION TESTS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 DIPSTICKS
6.3 DISPOSABLES
6.4 REAGENTS
7 KIDNEY FUNCTION TESTS MARKET, BY TYPE
7.1 INTRODUCTION
7.2 URINE TESTS
7.2.1 URINE PROTEIN TESTS
7.2.2 CREATININE CLEARANCE TESTS
7.2.3 MICROALBUMIN TESTS
7.3 BLOOD TESTS
7.3.1 SERUM CREATININE TESTS
7.3.2 GLOMERULAR FILTRATION RATE TESTS
7.3.3 BLOOD UREA NITROGEN TESTS
8 KIDNEY FUNCTION TESTS MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.3 DIAGNOSTIC LABORATORIES
8.4 RESEARCH LABORATORIES AND INSTITUTES
9 KIDNEY FUNCTION TESTS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 EU-5
9.3.2 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CONFERENCES & CAMPAIGNS TO CREATE AWARENESS OF KIDNEY DISEASES
9.4.2 CHINA
9.4.3 JAPAN
9.4.4 INDIA
9.4.5 REST OF ASIA PACIFIC (ROAPAC)
9.5 REST OF THE WORLD (ROW)
9.5.1 LATIN AMERICA
9.5.2 MIDDLE EAST
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 MARKET OVERVIEW
10.3 COMPETITIVE SCENARIO
10.3.1 EXPANSIONS
10.3.2 PRODUCT LAUNCHES
10.3.3 ACQUISITIONS
10.3.4 AGREEMENTS
10.3.5 REGULATORY APPROVALS
11 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 SIEMENS
11.2 BECKMAN COULTER
11.3 ROCHE
11.4 ABBOTT
11.5 SYSMEX
11.6 NOVA BIOMEDICAL
11.7 URIT MEDICAL
11.8 ARKRAY
11.9 OPTI MEDICAL
11.10 ACON LABORATORIES
11.11 77 ELEKTRONIKA
11.12 RANDOX LABORATORIES
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 KIDNEY FUNCTION TESTS: MARKET OVERVIEW
4.2 KIDNEY FUNCTION TESTS MARKET SHARE, BY PRODUCT AND REGION
4.3 KIDNEY FUNCTION TESTS MARKET, BY TYPE
4.4 KIDNEY FUNCTION TESTS MARKET, BY END USER
4.5 GEOGRAPHIC SNAPSHOT OF THE KIDNEY FUNCTION TESTS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of kidney disease
5.2.1.2 Growing prevalence of diabetes and hypertension
5.2.1.3 Rapid growth in geriatric population
5.2.1.4 Rise in consumption of alcohol
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable healthcare reforms in the US
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
6 KIDNEY FUNCTION TESTS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 DIPSTICKS
6.3 DISPOSABLES
6.4 REAGENTS
7 KIDNEY FUNCTION TESTS MARKET, BY TYPE
7.1 INTRODUCTION
7.2 URINE TESTS
7.2.1 URINE PROTEIN TESTS
7.2.2 CREATININE CLEARANCE TESTS
7.2.3 MICROALBUMIN TESTS
7.3 BLOOD TESTS
7.3.1 SERUM CREATININE TESTS
7.3.2 GLOMERULAR FILTRATION RATE TESTS
7.3.3 BLOOD UREA NITROGEN TESTS
8 KIDNEY FUNCTION TESTS MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.3 DIAGNOSTIC LABORATORIES
8.4 RESEARCH LABORATORIES AND INSTITUTES
9 KIDNEY FUNCTION TESTS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 EU-5
9.3.2 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CONFERENCES & CAMPAIGNS TO CREATE AWARENESS OF KIDNEY DISEASES
9.4.2 CHINA
9.4.3 JAPAN
9.4.4 INDIA
9.4.5 REST OF ASIA PACIFIC (ROAPAC)
9.5 REST OF THE WORLD (ROW)
9.5.1 LATIN AMERICA
9.5.2 MIDDLE EAST
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 MARKET OVERVIEW
10.3 COMPETITIVE SCENARIO
10.3.1 EXPANSIONS
10.3.2 PRODUCT LAUNCHES
10.3.3 ACQUISITIONS
10.3.4 AGREEMENTS
10.3.5 REGULATORY APPROVALS
11 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 SIEMENS
11.2 BECKMAN COULTER
11.3 ROCHE
11.4 ABBOTT
11.5 SYSMEX
11.6 NOVA BIOMEDICAL
11.7 URIT MEDICAL
11.8 ARKRAY
11.9 OPTI MEDICAL
11.10 ACON LABORATORIES
11.11 77 ELEKTRONIKA
11.12 RANDOX LABORATORIES
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 TOP 5 COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS (20–79 YEARS), 2015 VS. 2040
TABLE 2 FORECAST INCREASE IN POPULATION AGED 60 AND ABOVE (MILLIONS)
TABLE 3 GLOBAL KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 4 KIDNEY FUNCTION TESTS MARKET FOR DIPSTICKS, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 5 KIDNEY FUNCTION TESTS MARKET FOR DISPOSABLES, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 6 KIDNEY FUNCTION TESTS MARKET FOR REAGENTS, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 7 KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 8 URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 9 URINE PROTEIN TESTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 10 CREATININE CLEARANCE TESTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 11 MICROALBUMIN TESTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 12 BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 13 SERUM CREATININE TESTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 14 STAGES OF CHRONIC KIDNEY DISEASE
TABLE 15 GLOMERULAR FILTRATION RATE TESTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 16 BLOOD UREA NITROGEN TESTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 17 GLOBAL KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 18 KIDNEY FUNCTION TESTS MARKET FOR HOSPITALS, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 19 KIDNEY FUNCTION TESTS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 20 KIDNEY FUNCTION TESTS MARKET FOR RESEARCH LABORATORIES AND INSTITUTES, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 21 KIDNEY FUNCTION TESTS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
TABLE 22 NORTH AMERICA: KIDNEY FUNCTION TESTS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 23 NORTH AMERICA: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 24 NORTH AMERICA: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 25 NORTH AMERICA: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 26 NORTH AMERICA: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 27 NORTH AMERICA: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 28 US: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 29 US: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 30 US: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 31 US: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 32 US: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 33 CANADA: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 34 CANADA: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 35 CANADA: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 36 CANADA: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 37 CANADA: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 38 EUROPE: KIDNEY FUNCTION TESTS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 39 EUROPE: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 40 EUROPE: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 41 EUROPE: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 42 EUROPE: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 43 EUROPE: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 44 EU-5: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 45 EU-5: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 46 EU-5: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 47 EU-5: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 48 EU-5: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 49 ROE: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 50 ROE: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 51 ROE: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 52 ROE: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 53 ROE: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 54 AGING DEMOGRAPHICS IN ASIA PACIFIC COUNTRIES
TABLE 55 ASIA PACIFIC: KIDNEY FUNCTION TESTS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 56 ASIA PACIFIC: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 57 ASIA PACIFIC: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 58 ASIA PACIFIC: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 59 ASIA PACIFIC: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 60 ASIA PACIFIC: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 61 CHINA: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 62 CHINA: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 63 CHINA: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 64 CHINA: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 65 CHINA: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 66 JAPAN: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 67 JAPAN: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 68 JAPAN: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 69 JAPAN: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 70 JAPAN: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 71 INDIA: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 72 INDIA: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 73 INDIA: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 74 INDIA: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 75 INDIA: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 76 ROAPAC: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 77 ROAPAC: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 78 ROAPAC: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 79 ROAPAC: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 80 ROAPAC: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 81 ROW: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 82 ROW: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 83 ROW: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 84 ROW: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 85 ROW: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 86 EXPANSIONS (2014–2017)
TABLE 87 PRODUCT LAUNCHES (2014–2017)
TABLE 88 ACQUISITIONS (2014–2017)
TABLE 89 AGREEMENTS (2014–2017)
TABLE 90 REGULATORY APPROVALS (2014–2017)
TABLE 1 TOP 5 COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS (20–79 YEARS), 2015 VS. 2040
TABLE 2 FORECAST INCREASE IN POPULATION AGED 60 AND ABOVE (MILLIONS)
TABLE 3 GLOBAL KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 4 KIDNEY FUNCTION TESTS MARKET FOR DIPSTICKS, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 5 KIDNEY FUNCTION TESTS MARKET FOR DISPOSABLES, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 6 KIDNEY FUNCTION TESTS MARKET FOR REAGENTS, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 7 KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 8 URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 9 URINE PROTEIN TESTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 10 CREATININE CLEARANCE TESTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 11 MICROALBUMIN TESTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 12 BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 13 SERUM CREATININE TESTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 14 STAGES OF CHRONIC KIDNEY DISEASE
TABLE 15 GLOMERULAR FILTRATION RATE TESTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 16 BLOOD UREA NITROGEN TESTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 17 GLOBAL KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 18 KIDNEY FUNCTION TESTS MARKET FOR HOSPITALS, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 19 KIDNEY FUNCTION TESTS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 20 KIDNEY FUNCTION TESTS MARKET FOR RESEARCH LABORATORIES AND INSTITUTES, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
TABLE 21 KIDNEY FUNCTION TESTS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
TABLE 22 NORTH AMERICA: KIDNEY FUNCTION TESTS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 23 NORTH AMERICA: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 24 NORTH AMERICA: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 25 NORTH AMERICA: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 26 NORTH AMERICA: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 27 NORTH AMERICA: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 28 US: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 29 US: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 30 US: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 31 US: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 32 US: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 33 CANADA: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 34 CANADA: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 35 CANADA: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 36 CANADA: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 37 CANADA: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 38 EUROPE: KIDNEY FUNCTION TESTS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 39 EUROPE: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 40 EUROPE: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 41 EUROPE: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 42 EUROPE: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 43 EUROPE: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 44 EU-5: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 45 EU-5: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 46 EU-5: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 47 EU-5: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 48 EU-5: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 49 ROE: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 50 ROE: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 51 ROE: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 52 ROE: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 53 ROE: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 54 AGING DEMOGRAPHICS IN ASIA PACIFIC COUNTRIES
TABLE 55 ASIA PACIFIC: KIDNEY FUNCTION TESTS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 56 ASIA PACIFIC: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 57 ASIA PACIFIC: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 58 ASIA PACIFIC: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 59 ASIA PACIFIC: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 60 ASIA PACIFIC: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 61 CHINA: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 62 CHINA: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 63 CHINA: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 64 CHINA: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 65 CHINA: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 66 JAPAN: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 67 JAPAN: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 68 JAPAN: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 69 JAPAN: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 70 JAPAN: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 71 INDIA: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 72 INDIA: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 73 INDIA: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 74 INDIA: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 75 INDIA: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 76 ROAPAC: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 77 ROAPAC: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 78 ROAPAC: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 79 ROAPAC: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 80 ROAPAC: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 81 ROW: KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 82 ROW: KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 83 ROW: URINE TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 84 ROW: BLOOD TESTS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 85 ROW: KIDNEY FUNCTION TESTS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 86 EXPANSIONS (2014–2017)
TABLE 87 PRODUCT LAUNCHES (2014–2017)
TABLE 88 ACQUISITIONS (2014–2017)
TABLE 89 AGREEMENTS (2014–2017)
TABLE 90 REGULATORY APPROVALS (2014–2017)
LIST OF FIGURES
FIGURE 1 RESEARCH METHODOLOGY: GLOBAL KIDNEY FUNCTION TESTS MARKET
FIGURE 2 RESEARCH DESIGN: KIDNEY FUNCTION TESTS MARKET
FIGURE 3 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 SAMPLING FRAME: PRIMARY RESEARCH
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 GLOBAL KIDNEY FUNCTION TESTS MARKET, BY PRODUCT (2017)
FIGURE 9 GLOBAL KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2017 VS. 2022
FIGURE 10 GLOBAL KIDNEY FUNCTION TESTS MARKET, BY END USER, 2017 VS. 2022
FIGURE 11 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 12 RISING PREVALENCE OF KIDNEY DISEASES IS A MAJOR FACTOR DRIVING THE GROWTH OF THE KIDNEY FUNCTION TESTS MARKET
FIGURE 13 CHINA IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC KIDNEY FUNCTION TESTS MARKET IN 2017
FIGURE 14 URINE TESTS SEGMENT TO CONTINUE TO DOMINATE THE KIDNEY FUNCTION TESTS MARKET BETWEEN 2017 AND 2022
FIGURE 15 HOSPITAL SEGMENT TO CONTINUE TO DOMINATE THE KIDNEY FUNCTION TESTS MARKET BETWEEN 2017 AND 2022
FIGURE 16 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
FIGURE 17 DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 18 GLOBAL KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2017–2022
FIGURE 19 URINE TESTS SEGMENT TO DOMINATE THE KIDNEY FUNCTION TESTS MARKET IN 2017
FIGURE 20 GLOBAL KIDNEY FUNCTION TESTS MARKET, BY END USER, 2017–2022
FIGURE 21 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE MARKET IN 2017
FIGURE 22 NORTH AMERICA: KIDNEY FUNCTION TESTS MARKET SNAPSHOT
FIGURE 23 CAUSES OF KIDNEY FAILURE IN THE US
FIGURE 24 EUROPE: KIDNEY FUNCTION TESTS MARKET SNAPSHOT
FIGURE 25 REST OF EUROPE: NUMBER OF DIABETICS, BY COUNTRY, 2015 (MILLION CASES)
FIGURE 26 ASIA PACIFIC: KIDNEY FUNCTION TESTS MARKET SNAPSHOT
FIGURE 27 ROW: KIDNEY FUNCTION TESTS MARKET SNAPSHOT
FIGURE 28 KEY DEVELOPMENTS OF THE PROMINENT PLAYERS IN THE KIDNEY FUNCTION TESTS MARKET (2014–2017)
FIGURE 29 SIEMENS: COMPANY SNAPSHOT
FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 31 ROCHE: COMPANY SNAPSHOT
FIGURE 32 ABBOTT: COMPANY SNAPSHOT
FIGURE 33 SYSMEX: COMPANY SNAPSHOT
FIGURE 1 RESEARCH METHODOLOGY: GLOBAL KIDNEY FUNCTION TESTS MARKET
FIGURE 2 RESEARCH DESIGN: KIDNEY FUNCTION TESTS MARKET
FIGURE 3 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 SAMPLING FRAME: PRIMARY RESEARCH
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 GLOBAL KIDNEY FUNCTION TESTS MARKET, BY PRODUCT (2017)
FIGURE 9 GLOBAL KIDNEY FUNCTION TESTS MARKET, BY TYPE, 2017 VS. 2022
FIGURE 10 GLOBAL KIDNEY FUNCTION TESTS MARKET, BY END USER, 2017 VS. 2022
FIGURE 11 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 12 RISING PREVALENCE OF KIDNEY DISEASES IS A MAJOR FACTOR DRIVING THE GROWTH OF THE KIDNEY FUNCTION TESTS MARKET
FIGURE 13 CHINA IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC KIDNEY FUNCTION TESTS MARKET IN 2017
FIGURE 14 URINE TESTS SEGMENT TO CONTINUE TO DOMINATE THE KIDNEY FUNCTION TESTS MARKET BETWEEN 2017 AND 2022
FIGURE 15 HOSPITAL SEGMENT TO CONTINUE TO DOMINATE THE KIDNEY FUNCTION TESTS MARKET BETWEEN 2017 AND 2022
FIGURE 16 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
FIGURE 17 DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 18 GLOBAL KIDNEY FUNCTION TESTS MARKET, BY PRODUCT, 2017–2022
FIGURE 19 URINE TESTS SEGMENT TO DOMINATE THE KIDNEY FUNCTION TESTS MARKET IN 2017
FIGURE 20 GLOBAL KIDNEY FUNCTION TESTS MARKET, BY END USER, 2017–2022
FIGURE 21 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE MARKET IN 2017
FIGURE 22 NORTH AMERICA: KIDNEY FUNCTION TESTS MARKET SNAPSHOT
FIGURE 23 CAUSES OF KIDNEY FAILURE IN THE US
FIGURE 24 EUROPE: KIDNEY FUNCTION TESTS MARKET SNAPSHOT
FIGURE 25 REST OF EUROPE: NUMBER OF DIABETICS, BY COUNTRY, 2015 (MILLION CASES)
FIGURE 26 ASIA PACIFIC: KIDNEY FUNCTION TESTS MARKET SNAPSHOT
FIGURE 27 ROW: KIDNEY FUNCTION TESTS MARKET SNAPSHOT
FIGURE 28 KEY DEVELOPMENTS OF THE PROMINENT PLAYERS IN THE KIDNEY FUNCTION TESTS MARKET (2014–2017)
FIGURE 29 SIEMENS: COMPANY SNAPSHOT
FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 31 ROCHE: COMPANY SNAPSHOT
FIGURE 32 ABBOTT: COMPANY SNAPSHOT
FIGURE 33 SYSMEX: COMPANY SNAPSHOT
